Journal article
Hypoglycemia in type 2 diabetes: a critical review
Biomedicine & pharmacotherapy, Vol.58(10), pp.551-559
2004
DOI: 10.1016/j.biopha.2004.09.001
PMID: 15589062
Abstract
Hypoglycemia is the most important barrier to tight glycemic control. Although severe hypoglycemia is uncommon, milder events can occur so often that they represent a deterrent to intensifying treatment. High-risk patient behaviors are the most important cause for episodes for which a cause can be identified. Because symptoms are an unreliable way of establishing the diagnosis, SMBG should be considered for the patients at highest risk, particularly as they approach their glycemic targets. SMBG is superior to HbA1c in forecasting the hypoglycemia rate because it provides information about glucose variability—an independent risk factor. Patient education and medication changes are potential ways of reducing the hypoglycemia rate. However, it remains to be proven that patient education is beneficial in this regard.
Details
- Title: Subtitle
- Hypoglycemia in type 2 diabetes: a critical review
- Creators
- Glen H. Murata - University of New MexicoWilliam C. Duckworth - Carl T. Hayden Veterans Affairs Medical CenterRichard M. Hoffman - University of New MexicoChristopher S. Wendel - Southern Arizona VA Health Care SystemM. Jane Mohler - University of ArizonaJayendra H. Shah - University of Arizona
- Resource Type
- Journal article
- Publication Details
- Biomedicine & pharmacotherapy, Vol.58(10), pp.551-559
- Publisher
- Elsevier SAS
- DOI
- 10.1016/j.biopha.2004.09.001
- PMID
- 15589062
- ISSN
- 0753-3322
- eISSN
- 1950-6007
- Language
- English
- Date published
- 2004
- Academic Unit
- Epidemiology; General Internal Medicine; Internal Medicine
- Record Identifier
- 9984359853302771
Metrics
14 Record Views